I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Hauser, Wolfgang
413
results:
OpenAccess-fulltext X
Search for persons
X
Languages
english (322)
german (7)
Sorted by: Year
Sorted by: Relevance
?
1
Infants and newborns with atypical teratoid rhabdoid tumors..:
Nemes, Karolina
;
Johann, Pascal D
;
Steinbügl, Mona
...
http://dx.doi.org/10.18725/OPARU-51758. , 2024
Link:
https://doi.org/10.18725..
?
2
Calpeptin is a potent cathepsin inhibitor and drug candidat..:
Reinke, Patrick Y. A
;
de Souza, Edmarcia Elisa
;
Usenik, Aleksandra
...
info:eu-repo/semantics/altIdentifier/doi/10.3204/PUBDB-2023-06738. , 2023
Link:
https://bib-pubdb1.desy...
?
3
Supplementary Table S3 from Zoledronic Acid Add-on Therapy ..:
Raphael Koch
;
Lianne Haveman
;
Ruth Ladenstein
...
doi:10.1158/1078-0432.24825942.v1. , 2023
Link:
https://doi.org/10.1158/..
?
4
Calpeptin is a potent cathepsin inhibitor and drug candidat..:
Reinke, Patrick Y. A
;
de Souza, Edmarcia Elisa
;
Günther, Sebastian
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10584882/. , 2023
Link:
http://www.ncbi.nlm.nih...
?
5
Calpeptin is a potent cathepsin inhibitor and drug candidat..:
Patrick Y. A. Reinke
;
Edmarcia Elisa de Souza
;
Sebastian Günther
...
https://doi.org/10.1038/s42003-023-05317-9. , 2023
Link:
https://doi.org/10.1038/..
?
6
Roadmap für strombasierte Kraftstoffe 03EIV116A-G:
Aigner, Manfred
;
Aliabadi, Danial Esmaeili
;
Amri-Henkel, Andrea
...
https://elib.dlr.de/200260/1/Forschungsinitiative%20EiV_BEniVer_Roadmap%20f%C3%BCr%20strombasierte%20Kraftstoffe.pdf. , 2023
Link:
https://elib.dlr.de/2002..
?
7
Calpeptin is a potent cathepsin inhibitor and drug candidat..:
Reinke, Patrick Y. A
;
de Souza, Edmarcia Elisa
;
Günther, Sebastian
...
DOI:https://doi.org/10.1038/s42003-023-05317-9. , 2023
Link:
https://www.repo.uni-han..
?
8
Supplementary Data S2 from Zoledronic Acid Add-on Therapy f..:
Raphael Koch
;
Lianne Haveman
;
Ruth Ladenstein
...
doi:10.1158/1078-0432.24825969.v1. , 2023
Link:
https://doi.org/10.1158/..
?
9
Supplementary Data S1 from Zoledronic Acid Add-on Therapy f..:
Raphael Koch
;
Lianne Haveman
;
Ruth Ladenstein
...
doi:10.1158/1078-0432.24825972.v1. , 2023
Link:
https://doi.org/10.1158/..
?
10
Effect of Radiotherapy Dose on Outcome in Nonmetastatic Sar..:
Kersting, Josephine
;
Ranft, Andreas
;
Bhadri, Vivek
...
10.1016/j.adro.2023.101269. , 2023
Link:
http://hdl.handle.net/10..
?
11
Extracellular mitochondria drive CD8 T cell dysfunction in ..:
Tiwari-Heckler, Shilpa
;
Lee, Ghee Rye
;
Harbison, James
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9691787/. , 2023
Link:
http://www.ncbi.nlm.nih...
?
12
DataSheet1_CTCF deletion alters the pluripotency and DNA me..:
Deepika Puri
;
Catharina Maaßen
;
Monica Varona Baranda
...
doi:10.3389/fcell.2023.1302448.s001. , 2023
Link:
https://doi.org/10.3389/..
?
13
Supplementary Figure S2 from Zoledronic Acid Add-on Therapy..:
Raphael Koch
;
Lianne Haveman
;
Ruth Ladenstein
...
doi:10.1158/1078-0432.24825960.v1. , 2023
Link:
https://doi.org/10.1158/..
?
14
Supplementary Table S5 from Zoledronic Acid Add-on Therapy ..:
Raphael Koch
;
Lianne Haveman
;
Ruth Ladenstein
...
doi:10.1158/1078-0432.24825936.v1. , 2023
Link:
https://doi.org/10.1158/..
?
15
Table1_Everolimus plus reduced calcineurin inhibitor preven..:
Wolfgang Arns
;
Aurélie Philippe
;
Vanessa Ditt
...
doi:10.3389/frtra.2023.1264903.s002. , 2023
Link:
https://doi.org/10.3389/..
1-15